Get the Stockscreener App
18.33
1.19%
-0.22
Mediwound Ltd stock is traded at $18.33, with a volume of 23,640.
It is down -1.19% in the last 24 hours and up +1.72% over the past month.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
See More
Previous Close:
$18.55
Open:
$18.53
24h Volume:
23,640
Relative Volume:
0.23
Market Cap:
$198.11M
Revenue:
$19.85M
Net Income/Loss:
$-12.75M
P/E Ratio:
-13.28
EPS:
-1.38
Net Cash Flow:
$-21.94M
1W Performance:
-0.60%
1M Performance:
+1.72%
6M Performance:
+3.53%
1Y Performance:
+1.27%
1-Day Range:
$18.27
$18.72
1-Week Range:
$17.95
$18.79
52-Week Range:
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
18.33 | 237.84M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| May-02-25 | Initiated | Alliance Global Partners | Buy |
| Feb-28-25 | Initiated | Craig Hallum | Buy |
| Jul-16-24 | Reiterated | Maxim Group | Buy |
| Dec-22-22 | Initiated | Maxim Group | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Sep-23-20 | Initiated | BTIG Research | Buy |
| Nov-28-16 | Initiated | Aegis Capital | Buy |
| Aug-17-16 | Initiated | Wells Fargo | Outperform |
| Apr-16-14 | Initiated | Oppenheimer | Outperform |
View All
Mediwound Ltd Stock (MDWD) Latest News
U.S. Digital Wound Management Devices Market is Going to Boom: - openPR.com
Is MediWound Ltd. stock gaining market shareMarket Sentiment Review & Free High Return Stock Watch Alerts - newser.com
Technical analysis overview for MediWound Ltd. stockWeekly Trade Recap & Daily Chart Pattern Signals - newser.com
Visualizing MediWound Ltd. stock with heatmapsJuly 2025 Trends & AI Powered Trade Plan Recommendations - newser.com
Is MediWound Ltd. stock positioned for digital transformationExit Point & Stepwise Trade Signal Guides - newser.com
Combining price and volume data for MediWound Ltd.2025 Bull vs Bear & Stock Portfolio Risk Control - newser.com
Is a relief rally coming for MediWound Ltd. holdersEarnings Summary Report & Verified High Yield Trade Plans - newser.com
Is MediWound Ltd. stock a bargain at current levelsEarnings Recap Summary & Fast Entry Momentum Trade Alerts - newser.com
MediWound (NASDAQ:MDWD) Stock Price Crosses Above Fifty Day Moving AverageShould You Sell? - MarketBeat
When is the best time to exit MediWound Ltd.Weekly Loss Report & Risk Adjusted Swing Trade Ideas - newser.com
What does recent volatility data suggest for MediWound Ltd.July 2025 Trade Ideas & Entry Point Confirmation Signals - newser.com
Can MediWound Ltd. stock continue upward trend2025 Breakouts & Breakdowns & Consistent Profit Alerts - newser.com
What hedge fund activity signals for MediWound Ltd. stock2025 Pullback Review & AI Optimized Trading Strategy Guides - fcp.pa.gov.br
What drives MediWound Ltd stock pricePrice Support Zones & Free Stock Index Interpretations - earlytimes.in
How supply chain issues affect MediWound Ltd. stockMarket Activity Report & Community Trade Idea Sharing Platform - fcp.pa.gov.br
How to manage a losing position in MediWound Ltd.July 2025 Momentum & Safe Capital Growth Trade Ideas - newser.com
MediWound’s New Study on EscharEx: A Potential Game-Changer for Venous Leg Ulcers - TipRanks
Mediwound Ltd Stock (MDWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):